Sunrest LifescienceNSE:SUNREST 41 ROA % is 10.40% as of Mar. 2026, which is 117% above its 10-year median of 4.79. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Sunrest Lifescience ranks better than 68.52% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sunrest Lifescience's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹67.7 Mil.
Sunrest Lifescience's average Total Assets over the quarter that ended in Mar. 2026 was ₹650.3 Mil. Therefore, Sunrest Lifescience's annualized ROA % for the quarter that ended in Mar. 2026 was 10.40%.
The historical rank and industry rank for Sunrest Lifescience's ROA % or its related term are showing as below:
NSE:SUNREST'
s ROA % Range Over the Past 10 Years
Min: 0.59 Med: 4.79 Max: 13.74
Current: 5.2
During the past 7 years, Sunrest Lifescience's highest ROA % was 13.74%. The lowest was 0.59%. And the median was 4.79%.
NSE:SUNREST's ROA % is ranked better than 68.52% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.77
vs NSE:SUNREST: 5.20
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Sunrest Lifescience ROA % Related Terms
Sunrest Lifescience ROA % Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's ROA % distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Sunrest Lifescience (NSE:SUNREST) has a ROA % of 10.40% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sunrest Lifescience and its competitors. This is 117% above median its historical median of 4.79. Over the past decade, Sunrest Lifescience's ROA % has ranged from 0.59 to 13.74. According to the industry distribution chart, Sunrest Lifescience ranks #215 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 31.5%.
Is Sunrest Lifescience's ROA % too high?
Sunrest Lifescience's current ROA % of 10.40% is 117% above median its 10-year median of 4.79. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 13.74. The Healthcare Providers & Services industry median ROA % is 1.77. Sunrest Lifescience's value of 10.40% is 487.6% above this industry median. Based on the distribution chart, Sunrest Lifescience ranks #215 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's ROA % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #215 out of 683 companies for ROA %. This puts Sunrest Lifescience in the upper half of its industry. The industry median ROA % is 1.77. Sunrest Lifescience's value of 10.40% is 487.6% above this benchmark. Historically, Sunrest Lifescience's own ROA % has ranged from 0.59 to 13.74 over the past decade. While the company's 10-year median is 4.79 vs. the industry median of 1.77, Sunrest Lifescience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.77, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current ROA % of 10.40% is 487.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current ROA % is 10.40%, which is 117% above median its own 10-year median of 4.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current ROA % of 10.40%. The current ROA % is 10.40%, which is 117% above median its 10-year median of 4.79 and 487.6% above the Healthcare Providers & Services industry median of 1.77. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current ROA % is 10.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score
Get the complete analysis for NSE:SUNREST
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
